Contact
searchSearch
HMP Global

Volume 2 - Issue 4 - December 2022

Table of Contents • December 2022 • Volume 2 • Number 4
10/10/2022
10/10/2022
Journal of Critical Limb Ischemia
Original Contribution
Gender and Racial Disparities: The Impact on Diagnosis and Treatment of Peripheral Arterial Disease
11/14/2022
Mohammad M. Ansari, MD; Anthony Pham, BS; Cole Pollina, BS; Geoff Thomas, BS; Ardalan Naghian, BS; Mikal Ramon, MD; Steven Daley, BS; Nitish Mittal, MD; Victoria Acosta, BS; Marina Iskandir, MD; George Pliagas, MD, FACS, FRCSC; Dixon Santana, MD; Scott Shurmur, MD; Aliakbar Arvandi, MD; Sahil A. Parikh, MD, FACC, FSCAI; Fadi Saab, MD, FACC, FSCAI
Our study aims to determine whether racial and gender differences exist between Hispanic and non-Hispanic Americans regarding access and treatment for PAD care.
Our study aims to determine whether racial and gender differences exist between Hispanic and non-Hispanic Americans regarding access and treatment for PAD care.
Our study aims to determine...
11/14/2022
Journal of Critical Limb Ischemia
Original Contribution
Managing Access (Totally Percutaneous vs Surgical Cutdown) in the Setting of Large-Bore Sheaths That Could Lead to Delayed or Acute Limb Ischemia
11/23/2022
George Latsios, MD; Konstantinos Stathogiannis, MD, FACC; Vaios Tzifos, MD, PhD; Andreas Synetos, MD; Maria Drakopoulou, MD; Antonios Karanasos, MD; Athanasios Kolyviras, MD, PhD; Leonidas Koliastasis, MD; Pantelis Toskas, MD; Costas Tsioufis, MD; Konstantinos Toutouzas, MD
Consecutive patients scheduled for transfemoral TAVI were retrospectively grouped according to vascular access (percutaneous access and surgical cutdown). Primary endpoints were vascular and bleeding complications and 30-day mortality.
Consecutive patients scheduled for transfemoral TAVI were retrospectively grouped according to vascular access (percutaneous access and surgical cutdown). Primary endpoints were vascular and bleeding complications and 30-day mortality.
Consecutive patients scheduled...
11/23/2022
Journal of Critical Limb Ischemia
Original Contribution
Justification and Methods for the Critical Limb Ischemia & Chronic Kidney Disease—Amputations and Mortality (CLICK-A&M) Study Using the Premier Healthcare Database
12/27/2022
Anshul Saxena, PhD; Austin J. Pourmoussa, MD, MA; Rafey Khan, BS; Akash D. Nijhawan, BS; Venkataraghavan Ramamoorthy, MD, PhD; Zhenwei Zhang, PhD, MS; Don Parris, PhD, MPH; Raul E. Herrera, MD; Barry T. Katzen, MD, FACC, FACR, FSIR
The current study describes the underlying rationale, objectives, and methods to explore PAD, CLI, and CKD associations.
The current study describes the underlying rationale, objectives, and methods to explore PAD, CLI, and CKD associations.
The current study describes the...
12/27/2022
Journal of Critical Limb Ischemia
Original Contribution
Surgical Bypass of Femoral-Popliteal Arterial Disease: A Meta-analysis of Randomized and Prospective Trials
12/28/2022
Tayyab Shah, MD; Daniela Tirziu, PhD; M. Imran Ghare, MD; Yiping Yang, PhD; Roy Taoutel, MD; Samantha Gaston, BS; Cody Pietras, BA; Alexandra J. Lansky, MD
The study objective is to better define historical graft patency rates and adverse events following surgical bypass for femoral-popliteal arterial disease in patients with and without critical limb ischemia and compare them with contemporary...
The study objective is to better define historical graft patency rates and adverse events following surgical bypass for femoral-popliteal arterial disease in patients with and without critical limb ischemia and compare them with contemporary...
The study objective is to better...
12/28/2022
Journal of Critical Limb Ischemia
Original Contribution
Peripheral Artery Disease in Women
12/28/2022
Sasha P. Suárez Ferreira, BS; Anahita Dua, MD, MS, MBA, FACS
Peripheral artery disease (PAD) represents an important cause of morbidity and mortality worldwide. In general, women are a particularly susceptible population for their sex differences with men in the development of the disease. The...
Peripheral artery disease (PAD) represents an important cause of morbidity and mortality worldwide. In general, women are a particularly susceptible population for their sex differences with men in the development of the disease. The...
Peripheral artery disease (PAD)...
12/28/2022
Journal of Critical Limb Ischemia
Editorial/Commentary
The BEST-CLI Trial: Time for Pause or Action?
12/28/2022
Fadi Saab, MD, FACC, FSCAI; Konstantinos Stavroulakis, MD; Jos C. van den Berg, MD, PhD; Thomas Zeller, MD, PhD; Jihad A. Mustapha, MD, FACC, FSCAI; Barry T. Katzen, MD, FACC, FACR, FSIR; Andrew Holden, MBChB; Walter Dorigo, MD; Richard Neville, MD
The initial results of the long-awaited BEST-CLI (Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia) trial were recently published in the New England Journal of Medicine. There is a lack of prospective, randomized data to...
The initial results of the long-awaited BEST-CLI (Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia) trial were recently published in the New England Journal of Medicine. There is a lack of prospective, randomized data to...
The initial results of the...
12/28/2022
Journal of Critical Limb Ischemia

News

News
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k)...
09/08/2025
Journal of Critical Limb Ischemia
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/14/2025
Jos C. van den Berg, MD, PhD
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional...
08/14/2025
Journal of Critical Limb Ischemia
DR NEVILLE
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/14/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/14/2025
Journal of Critical Limb Ischemia
AMBITION BTK TRIAL FOR CLTI
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
07/24/2025
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective,...
07/24/2025
Vascular Disease Management

Stay in the Know

Journal of Critical Limb Ischemia Newsletter

December 2022 Volume 2 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use